Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy
Reid SE, Reid CA, Vermund SH. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy. International Journal Of STD & AIDS 2004, 15: 713-716. PMID: 15537453, DOI: 10.1258/0956462042395195.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyInfected personsAntiretroviral treatment programAntiretroviral drug therapyHuman immunodeficiency virusResource-limited settingsAdherence strategiesImmunodeficiency virusSaharan AfricaAdequate adherenceDrug therapyDrug costsLeprosy controlTreatment programTherapyTuberculosisLeprosyAdherenceControl programsPriorities for Antiretroviral Therapy Research in Sub-Saharan Africa
Zulu I, Schuman P, Musonda R, Chomba E, Mwinga K, Sinkala M, Chisembele M, Mwaba P, Kasonde D, Vermund SH. Priorities for Antiretroviral Therapy Research in Sub-Saharan Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2004, 36: 831-834. PMID: 15213567, PMCID: PMC2745050, DOI: 10.1097/00126334-200407010-00010.Peer-Reviewed Original ResearchConceptsAntiretroviral clinical trialsClinical trialsActive antiretroviral therapyAvailability of HAARTImpact of nonadherenceResource-constrained countriesResource-limited settingsHome-based care servicesAntiretroviral therapyPublic health contextART availabilityDrug costsClinical careTherapy researchConsensus conferenceViral resistanceResearch prioritiesCare servicesGeneric medicationsSuch trialsTherapeutic resourcesTrialsHAARTHIVUrgent research priority